IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i4p1400-d323486.html
   My bibliography  Save this article

A New Financing Model for Tuberculosis (TB) Care in China: Challenges of Policy Development and Lessons Learned from the Implementation

Author

Listed:
  • Qian Long

    (Global Health Research Center, Duke Kunshan University, Suzhou 215316, Jiangsu, China)

  • Weixi Jiang

    (Global Health Research Center, Duke Kunshan University, Suzhou 215316, Jiangsu, China)

  • Di Dong

    (Global Health Research Center, Duke Kunshan University, Suzhou 215316, Jiangsu, China)

  • Jiaying Chen

    (School of Policy & Management, Nanjing Medical University, Nanjing 211166, Jiangsu, China)

  • Li Xiang

    (Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430074, Hubei, China)

  • Qiang Li

    (School of Public Health, Xi’an Jiaotong University, Xi’an 710049, Shanxi, China)

  • Fei Huang

    (National Center for Tuberculosis Control and Prevention, China CDC, Beijing 102206, China)

  • Henry Lucas

    (Institute of Development Studies, University of Sussex, Brighton BN19RE, UK)

  • Shenglan Tang

    (Global Health Research Center, Duke Kunshan University, Suzhou 215316, Jiangsu, China
    Duke Global Health Institute, Duke University, Durham, NC 27710, USA)

Abstract

Background : With support from the Gates Foundation, the Chinese Center for Disease Control and Prevention (China CDC) introduced a new financing model for tuberculosis (TB) care. This paper reviews the development of the associated financing policies and payment methods in three project sites and analyzes the factors impacting on policy implementation and outcomes. Methods : We reviewed policy papers and other relevant documents issued in the project sites. Semi-structured qualitative interviews were conducted with key stakeholders at provincial, city and county levels. Thematic analysis was applied to identify themes and develop interpretations. Results : The China CDC guideline proposed the introduction of a case-based payment based on TB treatment clinical pathways, increased reimbursement rates and financial assistance for the poorest TB patients. Contrary to expectations, TB patients with complications and/or comorbidities were often excluded from the program by hospitals that were concerned the cost of care would exceed the case-based payment ceiling. In addition, doctors frequently prescribed services and/or drugs beyond the coverage of the benefit package for those in the program. Consequently, actual reimbursement rates were low and poor patients still faced a heavy financial burden, though the utilization of services increased, especially by poorer patients. Qualitative interviews revealed three main factors affecting payment policy implementation. They were: hospital managers’ concern on the potential for reduced revenue generation; their fear that patients would regard the service provided as sub-standard if they were not prescribed the full range of available treatments; and a lack of mechanisms to effectively monitor and support the implementation process. Conclusions : While the intervention had some success in improving access to TB care, the challenges of implementing the policy in what proved to be an unreceptive and often antagonistic context resulted in divergences from the original design that frustrated its aim of reducing the financial burden on patients.

Suggested Citation

  • Qian Long & Weixi Jiang & Di Dong & Jiaying Chen & Li Xiang & Qiang Li & Fei Huang & Henry Lucas & Shenglan Tang, 2020. "A New Financing Model for Tuberculosis (TB) Care in China: Challenges of Policy Development and Lessons Learned from the Implementation," IJERPH, MDPI, vol. 17(4), pages 1-11, February.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:4:p:1400-:d:323486
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/4/1400/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/4/1400/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Karen Eggleston & Li Ling & Meng Qingyue & Magnus Lindelow & Adam Wagstaff, 2008. "Health service delivery in China: a literature review," Health Economics, John Wiley & Sons, Ltd., vol. 17(2), pages 149-165, February.
    2. Linghan Shan & Ye Li & Ding Ding & Qunhong Wu & Chaojie Liu & Mingli Jiao & Yanhua Hao & Yuzhen Han & Lijun Gao & Jiejing Hao & Lan Wang & Weilan Xu & Jiaojiao Ren, 2016. "Patient Satisfaction with Hospital Inpatient Care: Effects of Trust, Medical Insurance and Perceived Quality of Care," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-18, October.
    3. Yang, Wei, 2016. "How does the pharmaceutical industry influence prescription? A qualitative study of provider payment incentives and drug remunerations in hospitals in Shanghai," Health Economics, Policy and Law, Cambridge University Press, vol. 11(4), pages 379-395, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Currie, Janet & Lin, Wanchuan & Zhang, Wei, 2011. "Patient knowledge and antibiotic abuse: Evidence from an audit study in China," Journal of Health Economics, Elsevier, vol. 30(5), pages 933-949.
    2. Yamei Bai & Aaron Yao & Yulei Song & Guihua Xu, 2018. "Redesigning the patient classification system in China: A pilot study," Nursing & Health Sciences, John Wiley & Sons, vol. 20(2), pages 181-186, June.
    3. Pan, Jay & Qin, Xuezheng & Li, Qian & Messina, Joseph P. & Delamater, Paul L., 2015. "Does hospital competition improve health care delivery in China?," China Economic Review, Elsevier, vol. 33(C), pages 179-199.
    4. Wenxin & W. & Bentum-Micah & G. & Zhiqiang & M. & Bing & L. & Asabea Addo & A. & Boadi & B.E. & Atuahene & A.S. & Bondzie-Micah & V., 2020. "The Influence of Encounter Service Quality on Patient Satisfaction: An Empirical Study in Chinese Public Hospitals," International Journal of Economics & Business Administration (IJEBA), International Journal of Economics & Business Administration (IJEBA), vol. 0(3), pages 461-477.
    5. Runtang Meng & Jingjing Li & Yunquan Zhang & Yong Yu & Yi Luo & Xiaohan Liu & Yanxia Zhao & Yuantao Hao & Ying Hu & Chuanhua Yu, 2018. "Evaluation of Patient and Medical Staff Satisfaction regarding Healthcare Services in Wuhan Public Hospitals," IJERPH, MDPI, vol. 15(4), pages 1-17, April.
    6. Zhou, Wenhui & Wan, Qiang & Zhang, Ren-Qian, 2017. "Choosing among hospitals in the subsidized health insurance system of China: A sequential game approach," European Journal of Operational Research, Elsevier, vol. 257(2), pages 568-585.
    7. Yunyun Jiang & Haitao Zheng & Tianhao Zhao, 2019. "Socioeconomic Status and Morbidity Rate Inequality in China: Based on NHSS and CHARLS Data," IJERPH, MDPI, vol. 16(2), pages 1-19, January.
    8. repec:hal:spmain:info:hdl:2441/6741 is not listed on IDEAS
    9. Xinxin Peng & Xiaolei Tang & Yijun Chen & Jinghua Zhang, 2021. "Ranking the Healthcare Resource Factors for Public Satisfaction with Health System in China—Based on the Grey Relational Analysis Models," IJERPH, MDPI, vol. 18(3), pages 1-13, January.
    10. Xilong Pan & Hassan H. Dib & Minmin Zhu & Ying Zhang & Yang Fan, 2009. "Absence of appropriate hospitalization cost control for patients with medical insurance: a comparative analysis study," Health Economics, John Wiley & Sons, Ltd., vol. 18(10), pages 1146-1162, October.
    11. Hou, Xiaohui & Coyne, Joseph, 2008. "The emergence of proprietary medical facilities in China," Health Policy, Elsevier, vol. 88(1), pages 141-151, October.
    12. Xiaojing Fan & Min Su & Yaxin Zhao & Duolao Wang, 2021. "Dissatisfaction with Local Medical Services for Middle-Aged and Elderly in China: What Is Relevant?," IJERPH, MDPI, vol. 18(8), pages 1-12, April.
    13. Xu, Weiwei & van de Ven, Wynand P.M.M., 2013. "Consumer choice among Mutual Healthcare Purchasers: A feasible option for China?," Social Science & Medicine, Elsevier, vol. 96(C), pages 277-284.
    14. Wenhui Mao & Yunyu Huang & Wen Chen, 2019. "An analysis on rational use and affordability of medicine after the implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-13, March.
    15. Audibert, Martine & Mathonnat, Jacky & Pelissier, Aurore & Huang, Xiao Xian & Ma, Anning, 2013. "Health insurance reform and efficiency of township hospitals in rural China: An analysis from survey data," China Economic Review, Elsevier, vol. 27(C), pages 326-338.
    16. Phuong Hung Vu & Ardeshir Sepehri & Linh Thi Thuy Tran, 2023. "Trends in out-of-pocket expenditure on facility-based delivery and financial protection of health insurance: findings from Vietnam’s Household Living Standard Survey 2006–2018," International Journal of Health Economics and Management, Springer, vol. 23(2), pages 237-254, June.
    17. Zhang, Cai Wen & Yang, Yuanhui, 2023. "Appraisal of regional hospital efficiency and healthcare quality in China: Impacts of subsidies and marketization," Socio-Economic Planning Sciences, Elsevier, vol. 89(C).
    18. Xu, Weiwei & van de Ven, Wynand P.M.M., 2009. "Purchasing health care in China: Competing or non-competing third-party purchasers?," Health Policy, Elsevier, vol. 92(2-3), pages 305-312, October.
    19. Deng, Zhongqi & Jiang, Nan & Song, Shunfeng & Pang, Ruizhi, 2021. "Misallocation and price distortions: A revenue decomposition of medical service providers in China," China Economic Review, Elsevier, vol. 65(C).
    20. Jongnam Hwang & Giang Thu Vu & Bach Xuan Tran & Thu Hong Thi Nguyen & Bang Van Nguyen & Long Hoang Nguyen & Huong Lan Thi Nguyen & Carl A Latkin & Cyrus S H Ho & Roger C M Ho, 2020. "Measuring satisfaction with health care services for Vietnamese patients with cardiovascular diseases," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-15, June.
    21. Adam Wagstaff & Winnie Yip & Magnus Lindelow & William C. Hsiao, 2009. "China's health system and its reform: a review of recent studies," Health Economics, John Wiley & Sons, Ltd., vol. 18(S2), pages 7-23, July.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:4:p:1400-:d:323486. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.